Peptide library · by goal
Peptides Researched for Longevity & Anti-Aging
Longevity is one of the most speculative corners of peptide research. The compounds gathered on this page are studied — in cells, in animals, and occasionally in small human cohorts — for their proposed roles in aging biology: telomere maintenance, mitochondrial function, clearance of senescent cells, and so-called "bioregulation" of gene expression. This is a reference for understanding which peptides appear in that conversation and what the science actually supports, not a recommendation to use any of them.
The honest picture is that robust human longevity evidence is essentially nonexistent here. Several of these peptides (epitalon, pinealon, thymalin) come from a single Russian gerontology and bioregulator research tradition whose findings have seen limited independent replication. Others (MOTS-c, humanin) are genuine mitochondrial-derived peptides with interesting biology but mostly preclinical and mechanistic data. FOXO4-DRI is an experimental senolytic with no human data and a risk flag. Only SS-31 (elamipretide) has been through controlled clinical trials — and those were for mitochondrial disease, with mixed results, and it is not an approved general-use medicine.
None of these are approved anti-aging treatments. Most carry research-chemical status, and research-market material is unverified and not the same as any studied clinical product. Where a peptide is an investigational or regionally-approved medicine, it is discussed here strictly for education — never promoted, never sourced, and never a substitute for a licensed clinician's judgment. Treat every longevity claim in this space with caution: the gap between an intriguing mechanism and a proven human benefit is wide, and for these peptides it has not been closed.
Not medical advice. Content on peptides.cx is an educational and community resource. It is not medical advice, diagnosis, treatment, prescribing guidance, dosing instruction, or emergency support. Always consult a qualified medical professional before making health-related decisions.
- 1
Epitalon
Evidence D — AnecdotalA tetrapeptide from Russian gerontology research, epitalon is discussed for proposed telomerase-related and pineal/circadian effects, though its human evidence is sparse and largely unreplicated.
- 2
MOTS-c
Evidence C — Early / PreclinicalA genuine mitochondrial-derived peptide studied for AMPK activation and metabolic regulation, MOTS-c draws longevity interest from its role in energy metabolism and exercise physiology — mostly on preclinical evidence.
- 3
SS-31 (Elamipretide)
Evidence B — Human, limitedThe mitochondria-targeting peptide SS-31 (elamipretide) is researched for stabilising cardiolipin and supporting mitochondrial function, making it the most clinically studied item here — though its trials were for mitochondrial disease, with mixed results and no general-use approval.
- 4
Humanin
Evidence C — Early / PreclinicalAnother mitochondrial-derived peptide, humanin is studied for proposed cytoprotective and metabolic signalling that ties it to aging biology, but its human data remains limited and largely observational.
- 5
A designed senolytic peptide intended to disrupt a FOXO4–p53 interaction in senescent cells, FOXO4-DRI is discussed in longevity circles purely on preclinical mouse data — it is highly experimental with no human evidence and a safety flag.
- 6
Thymalin
Evidence C — Early / PreclinicalA thymus-derived peptide preparation studied for immune modulation, thymalin appears in longevity discussion via the aging-immune-system angle, though independent evidence outside its regional clinical use is limited.
- 7
Pinealon
Evidence D — AnecdotalA short 'bioregulator' tripeptide from the same Russian research tradition, pinealon is discussed for proposed neuro and longevity effects on gene expression, but its evidence is weak and largely confined to its originating groups.
Popular comparisons
Frequently asked questions
- Do any peptides actually extend human lifespan?
- No peptide has been shown to extend human lifespan. The compounds researched for longevity rest almost entirely on cell and animal studies or small, unreplicated human cohorts. Intriguing mechanisms — telomere maintenance, mitochondrial support, senescent-cell clearance — have not translated into proven human benefit, and none of these peptides is an approved anti-aging treatment.
- Which longevity peptide has the strongest evidence?
- SS-31 (elamipretide) has the most rigorous data, having gone through controlled clinical trials — but those studied mitochondrial disease, produced mixed results, and did not lead to general-use approval. The others (epitalon, MOTS-c, humanin, thymalin, pinealon, FOXO4-DRI) rest on preclinical or regionally-limited evidence with limited independent replication.
- Why do so many of these peptides come from Russian research?
- Epitalon, pinealon, and thymalin trace to a Russian gerontology and 'bioregulator' research programme that proposed short peptides can influence gene expression and aging. That tradition generated most of the original claims, but its findings have seen limited independent replication elsewhere, which is a key reason the evidence remains weak.
- Are these peptides safe?
- Human safety data is limited or absent for most of them, and long-term profiles are largely unknown. FOXO4-DRI in particular is flagged as highly experimental with no human safety data. Research-market material is also unverified and is not the same as any studied clinical product. This page is educational and not a safety endorsement.
- Is this page medical advice?
- No. This is an educational reference describing which peptides are researched in the longevity context and what the evidence honestly shows. It contains no dosing, protocols, or sourcing, and does not recommend any peptide. Prescription and investigational compounds are discussed for education only. Consult a licensed clinician for any health decision.
Disclosure: This page may contain affiliate links and paid placements. If you click or purchase through them, peptides.cx may earn a commission. Sponsored listings and affiliate relationships are clearly marked and do not influence our editorial standards, moderation rules, or safety policies. Affiliate placement is not a medical endorsement.